Personal Initiative. Dynamic Pace. Meaningful Work.
Rapidly Expanding Industry, Limitless Career Potential
Sarepta and Catalent Expand Strategic Manufacturing Partnership
Catalent is pleased to announce the signing of a commercial supply agreement to manufacture delandistrogene moxeparvovec (SRP-9001), Sarepta’s most advanced gene therapy candidate for the treatment of Duchenne muscular dystrophy (DMD). Read full article here.
Join us where the exciting work of a start-up meets the backing of an established global organization. Contribute to the exciting evolution of Cell and Gene therapy and accelerate your career growth, while working alongside some of the best minds in the business.
It’s in our DNA to develop therapies that transform lives.
Who We AreCatalent is a global, high-growth, public company and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide.
We Are GlobalWith sites throughout North America, Europe, Latin America and Asia Pacific, there are endless opportunities for growth, development and global exposure. Connect with our global network across multiple continents today!
As a global organization with over 45 locations around the world, our diverse team works together in support of our mission to help people live better, healthier lives. If you want the opportunity to take personal initiative, work at a dynamic pace and positively impact the lives of millions of people across the globe, JOIN US!
Catalent fosters an environment in which individuals are respected, where differences and similarities are valued, and where everyone has opportunities to succeed. We strive to build a diverse and inclusive workplace.
At Catalent, responsibility and sustainability are integrated into the heart of our business. We have a global network of over 45 community ambassadors who organize various fundraisers and volunteer events throughout the year.
Regardless of your degree, Catalent is a great place to begin your career. Your passion for learning coupled with Catalent’s superior technologies will help drive the advancement of medicine in collaboration with leading pharmaceutical, biotech and health care innovators.